Today, we are proud to share our Q4 2024 financial results and highlights. $APLS https://bit.ly/4khL11L
Vice President, C Suite, Board, Commercial, Med Affairs, Clin. Dev, VP Life Sciences. Recruiter Orphan/Rare, Oncology start-up.
1moBest of Luck! Excited to see what 2025 holds for Apellis.